Abstracts deadline Friday 24 April 2026! Submit now

d
h
m
s

Abstracts deadline EXTENDED Friday 22 May 2026! Submit now

d
h
m
s
Korean College of Rheumatology
Days
Hrs
Mins
Register now
Search

Morning symposium 1: Phase III Clinical Trial Results of CT-P47(AVTOZMA) and Real-World Case Review (Sponsored by Celltrion)

10:25 - 11:25 30/10/26 Auditorium, Level 3

This session will review the Phase III clinical evidence for CT-P47 (AVTOZMA), including key efficacy, safety, and immunogenicity findings. The session will also explore the clinical application of tocilizumab through real-world case discussions, providing practical insights into treatment decision-making in patients with rheumatic diseases.

This session will review the Phase III clinical evidence for CT-P47 (AVTOZMA), including key efficacy, safety, and immunogenicity findings. The session will also explore the clinical application of tocilizumab through real-world case discussions, providing practical insights into treatment decision-making in patients with rheumatic diseases.

Chairperson/s

Presentations

Share

Key dates

Registrations
  • Early bird
    9 June 2026 EXTENDED 23 June 2026
  • Standard
    24 June to 28 September 2026
  • Late
    29 September to 1 November 2026
Abstracts
  • Submissions open
    3 September 2025 to 11:59PM AEST, 22 May 2026 CLOSED
  • Abstract acceptance notification
    mid-July 2026
  • Late abstract submissions open
    TBC
  • Late abstract submissions notification
    TBC
  • APLAR 2026 Congress
    28 October - 1 November 2026
  • Example
    Old date strike out EXTENDED
    Old date strike out CLOSED
Days
Hours
Minutes
Seconds

The countdown is on

Have you registered yet?
Don't miss your chance on being part of APLAR 2026 where live sessions feature the latest, best-in-class research and provide an opportunity to connect and stay apprised of the latest developments and innovations in the field.

REGISTER NOW
Days
Hours
Minutes
Seconds
Until 11:59PM AEST Friday 24 April, 2026

The countdown is on

Have you submitted your abstract yet?
Don't miss your chance on being part of APLAR 2026 where live sessions feature the latest, best-in-class research and provide an opportunity to connect and stay apprised of the latest developments and innovations in the field.

SUBMIT NOW